Sanofi-Aventis launches Genzyme takeover battle
France's Sanofi-Aventis on Monday launched an $18.5 billion hostile takeover attempt for Genzyme Corp., escalating the battle after management of the US biotech company twice rejected its offer. At $69 per share,
Sanofi-Aventis launches hostile bid for Genzyme AFP

Drug stocks sluggish; Sanofi bids for Genzyme MarketWatch
Candidates on potential Genzyme takeover
Reuters -Proactive Investors USA & Canada -Xconomy
all 898 news articles »



Post a Comment
* Your Name:

* Your Email:

(NEVER publicly displayed)
Website URL:
* Security Image:
Security Image Generate New
Copy the numbers and letters from the security image:
* Your Comment:
No HTML tags are permitted in comments.
By submitting, you agree with our Publishing Policy. Please note that we may publish your comment in other sections of this site.